BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 18670856)

  • 1. Voxel- and ROI-based statistical analyses of PET parameters for guidance in the surgical treatment of intractable mesial temporal lobe epilepsy.
    Ohta Y; Nariai T; Ishii K; Ishiwata K; Mishina M; Senda M; Hirakawa K; Ohno K
    Ann Nucl Med; 2008 Jul; 22(6):495-503. PubMed ID: 18670856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of extent analysis for statistical parametric mapping with asymmetry index using inter-ictal FGD-PET in mesial temporal lobe epilepsy.
    Soma T; Momose T; Takahashi M; Koyama K; Kawai K; Murase K; Ohtomo K
    Ann Nucl Med; 2012 May; 26(4):319-26. PubMed ID: 22311414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis.
    Komoto D; Iida K; Higaki T; Kaichi Y; Takauchi K; Arihiro K; Kakita A; Hirokawa Y; Awai K
    Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voxel-based comparison of preoperative FDG-PET between mesial temporal lobe epilepsy patients with and without postoperative seizure-free outcomes.
    Takahashi M; Soma T; Kawai K; Koyama K; Ohtomo K; Momose T
    Ann Nucl Med; 2012 Nov; 26(9):698-706. PubMed ID: 22810894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy.
    Padma MV; Simkins R; White P; Satter M; Christian BT; Dunigan K; Lee C; Jacobs M; Mukherjee J; Mantil JC
    Neurol India; 2004 Dec; 52(4):457-62. PubMed ID: 15626833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy.
    Vivash L; Gregoire MC; Lau EW; Ware RE; Binns D; Roselt P; Bouilleret V; Myers DE; Cook MJ; Hicks RJ; O'Brien TJ
    J Nucl Med; 2013 Aug; 54(8):1270-7. PubMed ID: 23857513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting seizure-free status for temporal lobe epilepsy patients undergoing surgery: prognostic value of quantifying maximal metabolic asymmetry extending over a specified proportion of the temporal lobe.
    Lin TW; de Aburto MA; Dahlbom M; Huang LL; Marvi MM; Tang M; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2007 May; 48(5):776-82. PubMed ID: 17475967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy.
    Joo EY; Hong SB; Han HJ; Tae WS; Kim JH; Han SJ; Seo DW; Lee KH; Hong SC; Lee M; Kim S; Kim BT
    Brain; 2005 Aug; 128(Pt 8):1802-10. PubMed ID: 15872014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis.
    Yankam Njiwa J; Gray KR; Costes N; Mauguiere F; Ryvlin P; Hammers A
    Neuroimage Clin; 2015; 7():122-31. PubMed ID: 25610774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorodeoxyglucose-positron emission tomographic imaging for the diagnosis of mesial temporal lobe epilepsy.
    Boling WW; Lancaster M; Kraszpulski M; Palade A; Marano G; Puce A
    Neurosurgery; 2008 Dec; 63(6):1130-8; discussion 1138. PubMed ID: 19057325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of FDG-PET with 3D-SSP for surgical outcomes in patients with temporal lobe epilepsy.
    Higo T; Sugano H; Nakajima M; Karagiozov K; Iimura Y; Suzuki M; Sato K; Arai H
    Seizure; 2016 Oct; 41():127-33. PubMed ID: 27552380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM.
    Kim YK; Lee DS; Lee SK; Kim SK; Chung CK; Chang KH; Choi KY; Chung JK; Lee MC
    J Nucl Med; 2003 Jul; 44(7):1006-12. PubMed ID: 12843213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved cerebral function in mesial temporal lobe epilepsy after subtemporal amygdalohippocampectomy.
    Takaya S; Mikuni N; Mitsueda T; Satow T; Taki J; Kinoshita M; Miyamoto S; Hashimoto N; Ikeda A; Fukuyama H
    Brain; 2009 Jan; 132(Pt 1):185-94. PubMed ID: 18790818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of an objective method for localizing bilateral cortical FDG PET abnormalities to guide the resection of epileptic foci.
    Muzik O; Pourabdollah S; Juhasz C; Chugani DC; Janisse J; Draghici S
    IEEE Trans Biomed Eng; 2005 Sep; 52(9):1574-81. PubMed ID: 16189970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between bilateral temporal hypometabolism and EEG findings for mesial temporal lobe epilepsy: analysis of 18F-FDG PET using SPM.
    Kim MA; Heo K; Choo MK; Cho JH; Park SC; Lee JD; Yun M; Park HJ; Lee BI
    Seizure; 2006 Jan; 15(1):56-63. PubMed ID: 16386927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI.
    Koepp MJ; Hammers A; Labbé C; Woermann FG; Brooks DJ; Duncan JS
    Neurology; 2000 Jan; 54(2):332-9. PubMed ID: 10668692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: a comparison with IMP SPECT and FDG PET.
    Kaneko K; Sasaki M; Morioka T; Koga H; Abe K; Sawamoto H; Ohya N; Yoshiura T; Mihara F; Honda H
    Nucl Med Commun; 2006 Nov; 27(11):893-9. PubMed ID: 17021430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal epilepsy lesions may be detected by the voxel-based quantitative analysis of brain FDG-PET images using an original block-matching normalization software.
    Verger A; Yagdigul Y; Van Der Gucht A; Poussier S; Guedj E; Maillard L; Malandain G; Hossu G; Fay R; Karcher G; Marie PY
    Ann Nucl Med; 2016 May; 30(4):272-8. PubMed ID: 26841946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FCWAY and 18F-FDG PET in MRI-negative temporal lobe epilepsy.
    Liew CJ; Lim YM; Bonwetsch R; Shamim S; Sato S; Reeves-Tyer P; Herscovitch P; Dustin I; Bagic A; Giovacchini G; Theodore WH
    Epilepsia; 2009 Feb; 50(2):234-9. PubMed ID: 18801033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy.
    Szelies B; Weber-Luxenburger G; Pawlik G; Kessler J; Holthoff V; Mielke R; Herholz K; Bauer B; Wienhard K; Heiss WD
    Neuroimage; 1996 Apr; 3(2):109-18. PubMed ID: 9345482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.